Ani Pharmaceuticals Inc
ANIP
Revenue
138.04M
▲610.00k▲0.4439%
3 Months ChangeAssets
920.75M
▲6.23M▲0.6811%
3 Months ChangeLiabilities
440.14M
▲2.43M▲0.5556%
3 Months ChangeFree Cash Flow
13.69M
▼-5.39M▼-28.24%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-20
Form 8-K
ID: 0001023024-24-000093
2024-09-16
Form 8-K
ID: 0001023024-24-000088
2024-08-13
Form 8-K
ID: 0000950103-24-012144
2024-08-08
Form 8-K
ID: 0000950103-24-011897
2024-08-07
Form 8-K
ID: 0000950103-24-011822
2024-08-06
Form 10-Q
ID: 0001023024-24-000085
2024-08-06
Form 8-K
ID: 0001023024-24-000083
2024-06-24
Form 8-K
ID: 0001023024-24-000070
2024-06-05
Form 8-K
ID: 0001023024-24-000067
2024-05-23
Form 8-K
ID: 0001023024-24-000063